These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1857 related items for PubMed ID: 17667567
1. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study. de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567 [Abstract] [Full Text] [Related]
2. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK, Rex C, Sielenkämper AW, Claudius C, Larsen PB, Prins ME, Eikermann M, Khuenl-Brady KS. Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227 [Abstract] [Full Text] [Related]
3. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine. Lee C, Jahr JS, Candiotti KA, Warriner B, Zornow MH, Naguib M. Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176 [Abstract] [Full Text] [Related]
4. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK. Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [Abstract] [Full Text] [Related]
5. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM. Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124 [Abstract] [Full Text] [Related]
6. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, Wulf H. Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873 [Abstract] [Full Text] [Related]
7. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. Sacan O, White PF, Tufanogullari B, Klein K. Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210 [Abstract] [Full Text] [Related]
8. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane. Vanacker BF, Vermeyen KM, Struys MM, Rietbergen H, Vandermeersch E, Saldien V, Kalmar AF, Prins ME. Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209 [Abstract] [Full Text] [Related]
9. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial. Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA. Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265 [Abstract] [Full Text] [Related]
10. The effect of residual neuromuscular blockade on the speed of reversal with sugammadex. White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME. Anesth Analg; 2009 Mar 01; 108(3):846-51. PubMed ID: 19224792 [Abstract] [Full Text] [Related]
13. Neuromuscular transmission: new concepts and agents. de Boer HD. J Crit Care; 2009 Mar 01; 24(1):36-42. PubMed ID: 19272537 [Abstract] [Full Text] [Related]
14. Reversal of profound rocuronium or vecuronium-induced neuromuscular block with sugammadex in isoflurane-anaesthetised dogs. Mosing M, Auer U, West E, Jones RS, Hunter JM. Vet J; 2012 Jun 01; 192(3):467-71. PubMed ID: 22030475 [Abstract] [Full Text] [Related]